Protein 1700007B14Rik Activators are a set of chemical compounds that indirectly enhance the functional activity of Protein 1700007B14Rik through modulation of various signaling pathways. Forskolin, by increasing cAMP, activates PKA which in turn may phosphorylate substrates related to Protein 1700007B14Rik, thus enhancing its activity. The activation of PKC by PMA might similarly promote Protein 1700007B14Rik activity through phosphorylation mechanisms. Ionomycin and A23187, both acting as calcium ionophores, elevate intracellular calcium that can activate calcium-dependent proteins, potentially affecting Protein 1700007B14Rik. The release of nitric oxide by SNAP and the subsequent increase in cGMP levels could also augment Protein 1700007B14Rik function through cGMP-dependent signaling. The kinase inhibitors such as EGCG, LY294002, SB203580, U0126, and Wortmannin may indirectly enhance Protein 1700007B14Rik activity by inhibiting kinases that negatively regulate it or pathways that compete for its substrates. Sildenafil and Zaprinast, both PDE5 inhibitors, raise cGMP levels, which could further potentiate Protein 1700007B14Rik's activity through similar cGMP-dependent mechanisms.
These activators collectively function through a range of biochemical mechanisms to support the enhancement of Protein 1700007B14Rik without directly increasing its expression or requiring direct binding to the protein. For instance, EGCG's kinase inhibition might relieve Protein 1700007B14Rik from negative regulation, while LY294002 and Wortmannin's PI3K inhibitory effects could shift cellular signaling dynamics to favor pathways where Protein 1700007B14Rik is more actively involved. SB203580 and U0126, by modulating the MAPK signaling cascade, may also tilt the balance in favor of Protein 1700007B14Rik's functional pathways. In this way, each compound, through its unique interaction with cellular signaling, contributes to an overall enhancement of Protein 1700007B14Rik's activity, delineating a complex network of regulatory influences that collectively determine the protein's functional state.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates Protein Kinase C (PKC), which could phosphorylate target proteins that interact with or regulate Protein 1700007B14Rik, thereby enhancing its activity in cellular signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, potentially activating calcium-dependent protein kinases which may influence the phosphorylation state and activity of Protein 1700007B14Rik. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain protein kinases, potentially reducing negative regulatory influences on Protein 1700007B14Rik, thereby resulting in its enhanced activation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, which could lead to a reduction in the PI3K/AKT pathway activity, potentially relieving inhibitory control over Protein 1700007B14Rik and enhancing its activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which could shift signaling pathways balance, indirectly leading to the enhancement of Protein 1700007B14Rik activity by modulating related stress response pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium concentration, which might activate calcium-binding proteins that modulate the activity of Protein 1700007B14Rik. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, another PI3K inhibitor, could indirectly enhance the activity of Protein 1700007B14Rik by modulating the PI3K/AKT pathway, shifting the balance of signaling towards pathways where Protein 1700007B14Rik is active. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, leading to increased cGMP levels, which could in turn enhance the functional activity of Protein 1700007B14Rik through cGMP-dependent signaling mechanisms. | ||||||